Contact
Please use this form to send email to PR contact of this press release:
Foamix Announces Dosing of First Patient in Phase 3 Acne Studies for Minocycline Foam FMX101
TO:
Please use this form to send email to PR contact of this press release:
Foamix Announces Dosing of First Patient in Phase 3 Acne Studies for Minocycline Foam FMX101
TO: